Psych Capital
Overview
Psych Capital is a UK-based venture capital firm investing in psychedelic healthcare companies across Europe and North America. The firm focuses on emerging European startups in the psychedelic space, aiming to support innovative companies in the mental health sector. Psych Capital's investment strategy includes providing funding to early-stage companies developing psychedelic-based therapies and treatments. The firm's portfolio includes companies such as Awakn Life Sciences, a UK-based biotechnology company specializing in psychedelic medicine. In 2021, Psych Capital acquired a 2% stake in Awakn Life Sciences, reflecting its commitment to advancing psychedelic healthcare. Psych Capital's investments are guided by a vision to unlock the commercial potential of psychedelics and address the growing mental health crisis through innovative solutions. Psych Capital's investment philosophy centers on identifying and supporting companies that are at the forefront of psychedelic research and development. By focusing on early-stage companies, the firm aims to foster growth and innovation in the psychedelic healthcare industry, contributing to the advancement of treatments for mental health disorders. Psych Capital's approach combines financial support with strategic guidance to help portfolio companies navigate the complex regulatory and scientific landscapes of the psychedelic sector.
Investment Focus
- Companies developing psychedelic-based therapies
- Early-stage companies in the mental health sector
- Innovative solutions addressing mental health disorders
Portfolio Companies
Reach Psych Capital directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Psych Capital
What sectors does Psych Capital invest in?
Psych Capital invests in Healthcare, Digital Health, Pharmaceuticals, Medical Devices, Diagnostics and Biotechnology, and is based in United Kingdom. Psych Capital is listed as a venture capital in the ConnectSafely investor database.
What stage does Psych Capital invest at?
Psych Capital backs companies at Seed, Early Stage, Series A, Series B, Growth and Late Stage, writing cheques of 1M - 50M.
Which regions does Psych Capital invest in?
Psych Capital invests across United States, United Kingdom, Canada, Germany, France and Italy.
What companies has Psych Capital invested in?
Psych Capital's portfolio includes Awakn Life Sciences.
Last updated · Source: ConnectSafely investor database
